Panacea Index Logo

Command Palette

Search for a command to run...

Dietary nitrate supplementation in cardiovascular health: an ergogenic aid or exercise therapeutic?

American journal of physiology. Heart and circulatory physiology
January 1, 1970
Mary N Woessner et al. (5 authors)
Journal ArticleReviewHuman Study
Study Details

Study Goal

The researchers aimed to evaluate the therapeutic potential of inorganic nitrate supplementation (e.g., from beetroot) in improving exercise tolerance and quality of life in cardiovascular disease patients, compared to its ergogenic effects in healthy athletes.

Results Summary

Nitrate supplementation increased plasma nitrite, which may enhance nitric oxide availability, leading to benefits like reduced blood pressure and improved blood flow. While results in healthy athletes were inconsistent due to methodological variability, clinical populations (e.g., cardiovascular disease patients) showed more promising outcomes, particularly in addressing oxygen transport limitations and exercise intolerance.

Population

Healthy recreational/competitive athletes and clinical populations (primarily cardiovascular disease patients).

Effective Dosage

Not specified

Duration

Not specified

Interactions

None mentioned

Extracted Claims (9)
InterventionDirectionEndpointPopulationDosageImpactClaim #
Oral consumption of inorganic nitrate
increase
circulating plasma nitrite concentration
-
-
has been shown to increase
#1
Oral consumption of inorganic nitrate
decrease
blood pressure
-
-
beneficial physiological effects include a reduction in
#2
Oral consumption of inorganic nitrate
neutral
platelet aggregation
-
-
beneficial physiological effects include modification of
#3
Oral consumption of inorganic nitrate
increase
limb blood flow
-
-
beneficial physiological effects include increases in
#4
nitrate supplementation
no change
ergogenic benefits
healthy recreational and competitive athletes
-
ergogenic benefits are currently unclear
#5
inorganic nitrate supplementation
increase
exercise tolerance
patients with cardiovascular diseases
-
as a therapeutic intervention to restore
#6
inorganic nitrate supplementation
increase
quality of life
patients with cardiovascular diseases
-
as a therapeutic intervention to improve
#7
inorganic nitrate supplementation
increase
effectiveness
patients with cardiovascular disease
-
may be more effective in
#8
inorganic nitrate supplementation
increase
effectiveness
patients with cardiovascular disease
-
may be more effective than as ergogenic aid in
#9
Abstract

Oral consumption of inorganic nitrate, which is abundant in green leafy vegetables and roots, has been shown to increase circulating plasma nitrite concentration, which can be converted to nitric oxide in low oxygen conditions. The associated beneficial physiological effects include a reduction in blood pressure, modification of platelet aggregation, and increases in limb blood flow. There have been numerous studies of nitrate supplementation in healthy recreational and competitive athletes; however, the ergogenic benefits are currently unclear due to a variety of factors including small sample sizes, different dosing regimens, variable nitrate conversion rates, the heterogeneity of participants' initial fitness levels, and the types of exercise tests used. In clinical populations, the study results seem more promising, particularly in patients with cardiovascular diseases who typically present with disruptions in the ability to transport oxygen from the atmosphere to working tissues and reduced exercise tolerance. Many of these disease-related, physiological maladaptations, including endothelial dysfunction, increased reactive oxygen species, reduced tissue perfusion, and muscle mitochondrial dysfunction, have been previously identified as potential targets for nitric oxide restorative effects. This review is the first of its kind to outline the current evidence for inorganic nitrate supplementation as a therapeutic intervention to restore exercise tolerance and improve quality of life in patients with cardiovascular diseases. We summarize the factors that appear to limit or maximize its effectiveness and present a case for why it may be more effective in patients with cardiovascular disease than as ergogenic aid in healthy populations.

Medical Subject Headings (MeSH)
AnimalsCardiovascular DiseasesDiet, HealthyDietary SupplementsEndothelium, VascularExercise TherapyExercise ToleranceHumansNitratesPerformance-Enhancing SubstancesProtective FactorsRisk FactorsTreatment Outcome
Study Links
Quality Scores
SafetyNot Assessed
Efficacy75/10
Quality80/10
Citation Metrics
Total Citations33
Citations/Year4.7
Relative Citation Ratio1.80
NIH Percentile71.2%
Research Impact Scores
APT Score0.75
Weight Score0.90
Normalized Score0.66
Related Supplements